Swiss National Bank’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Swiss National Bank’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-280,000	Closed	-$5.22M	–	2833
2022 Q1	$5.22M	Buy	280,000 +21,300	+8%	+$383K	﹤0.01%	1406
2021 Q4	$5.53M	Buy	258,700 +41,700	+19%	+$822K	﹤0.01%	1402
2021 Q3	$4.01M	Buy	217,000 +10,000	+5%	+$201K	﹤0.01%	1621
2021 Q2	$4.43M	Buy	+207,000	New	+$4.21M	﹤0.01%	1585

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Swiss National Bank's OCDX Position: Q2 2022 in Review

Swiss National Bank sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 280,000 shares — an estimated $5.22M sold.

Swiss National Bank first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $5.53M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Swiss National Bank reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Swiss National Bank sold 280,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $5.22M.
Swiss National Bank first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
Swiss National Bank's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.53M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.